JP Morgan Chase’s HealthStream HSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.2M Buy
635,565
+181,827
+40% +$4.26M ﹤0.01% 2344
2026
Q1
$9.57M Buy
453,738
+841
+0.2% +$17.9K ﹤0.01% 2716
2025
Q4
$10.4M Buy
452,897
+20,075
+5% +$505K ﹤0.01% 2637
2025
Q3
$12.2M Buy
432,822
+184,917
+75% +$5.08M ﹤0.01% 2542
2025
Q2
$6.86M Buy
247,905
+186,231
+302% +$5.5M ﹤0.01% 2873
2025
Q1
$1.98M Sell
61,674
-42,794
-41% -$1.39M ﹤0.01% 3871
2024
Q4
$3.32M Buy
104,468
+47,264
+83% +$1.46M ﹤0.01% 3744
2024
Q3
$1.65M Buy
57,204
+9,017
+19% +$258K ﹤0.01% 4146
2024
Q2
$1.34M Sell
48,187
-17,390
-27% -$464K ﹤0.01% 4070
2024
Q1
$1.75M Buy
65,577
+7,423
+13% +$199K ﹤0.01% 3945
2023
Q4
$1.57M Buy
58,154
+9,821
+20% +$244K ﹤0.01% 4013
2023
Q3
$1.04M Sell
48,333
-4,153
-8% -$91.7K ﹤0.01% 4040
2023
Q2
$1.29M Buy
52,486
+3,333
+7% +$82.7K ﹤0.01% 3865
2023
Q1
$1.33M Buy
49,153
+6,069
+14% +$151K ﹤0.01% 3833
2022
Q4
$1.07M Buy
43,084
+2,422
+6% +$58.1K ﹤0.01% 3993
2022
Q3
$864K Sell
40,662
-60
-0.1% -$1.36K ﹤0.01% 4110
2022
Q2
$884K Buy
40,722
+1,851
+5% +$36.9K ﹤0.01% 4188
2022
Q1
$773K Sell
38,871
-35,685
-48% -$807K ﹤0.01% 4434
2021
Q4
$1.97M Buy
74,556
+10,117
+16% +$268K ﹤0.01% 3875
2021
Q3
$1.84M Buy
64,439
+13,702
+27% +$400K ﹤0.01% 3848
2021
Q2
$1.42M Buy
50,737
+20,324
+67% +$511K ﹤0.01% 4044
2021
Q1
$681K Sell
30,413
-3,410
-10% -$81.3K ﹤0.01% 4484
2020
Q4
$738K Sell
33,823
-6,280
-16% -$126K ﹤0.01% 4139
2020
Q3
$805K Sell
40,103
-15,859
-28% -$337K ﹤0.01% 3755
2020
Q2
$1.24M Sell
55,962
-62,408
-53% -$1.45M ﹤0.01% 3393
2020
Q1
$2.84M Sell
118,370
-125,148
-51% -$3.14M ﹤0.01% 2709
2019
Q4
$6.62M Sell
243,518
-24,743
-9% -$681K ﹤0.01% 2462
2019
Q3
$6.95M Buy
268,261
+20,567
+8% +$552K ﹤0.01% 2416
2019
Q2
$6.45M Buy
247,694
+113,684
+85% +$2.99M ﹤0.01% 2439
2019
Q1
$3.76M Buy
134,010
+84,479
+171% +$2.22M ﹤0.01% 2825
2018
Q4
$1.2M Buy
49,531
+17,790
+56% +$461K ﹤0.01% 3628
2018
Q3
$985K Sell
31,741
-36,334
-53% -$1.09M ﹤0.01% 3929
2018
Q2
$1.86M Buy
68,075
+33,708
+98% +$894K ﹤0.01% 3468
2018
Q1
$853K Buy
34,367
+3,533
+11% +$84.9K ﹤0.01% 3769
2017
Q4
$714K Buy
30,834
+27,486
+821% +$647K ﹤0.01% 3898
2017
Q3
$78K Buy
+3,348
New +$79.6K ﹤0.01% 4366
2017
Q1
Sell
-18,388
Closed -$461K 5131
2016
Q4
$461K Buy
+18,388
New +$473K ﹤0.01% 3812
2016
Q3
Sell
-2,285
Closed -$61K 4656
2016
Q2
$61K Buy
+2,285
New +$53.7K ﹤0.01% 3999
2014
Q1
Sell
-33,578
Closed -$1.09M 3732
2013
Q4
$1.09M Buy
33,578
+305
+0.9% +$10.4K ﹤0.01% 3108
2013
Q3
$1.26M Sell
33,273
-14,231
-30% -$464K ﹤0.01% 3122
2013
Q2
$1.2M Buy
+47,504
New +$1.15M ﹤0.01% 3133

Other funds holding HSTM

JP Morgan Chase's HSTM Position: Q2 2026 in Review

JP Morgan Chase increased its HealthStream (HSTM) stake by 40% in Q2 2026, buying an estimated $4.26M and bringing the position to 635,565 shares worth $17.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2344.

JP Morgan Chase first reported a position in HSTM in Q2 2013 and has held it in 41 quarters since. 219 funds tracked by Wall St. Rank hold HSTM as of Q2 2026.

  • JP Morgan Chase held 635,565 shares of HealthStream worth $17.2M as of Q2 2026.
  • JP Morgan Chase bought 181,827 HealthStream shares in Q2 2026, an estimated $4.26M.
  • HealthStream made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #2344 holding.
  • JP Morgan Chase first reported a position in HealthStream in Q2 2013 and has held it in 41 quarters since.
  • 219 funds tracked by Wall St. Rank held HealthStream as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.